Use when locking the study design and internal-validity safeguards for a JAMA clinical manuscript (RCT, cohort, diagnostic, or systematic review). Strengthens design choices; it does NOT pick the reporting checklist or run the statistics.
Scanned 6/5/2026
Install to Claude Code
npx -y skills add brycewang-stanford/Awesome-Journal-Skills --skill jama-study-design --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Jama Study Design?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/brycewang-stanford-jama-study-design)More formats (shields.io, HTML) on the badges page.
---
name: jama-study-design
description: Use when locking the study design and internal-validity safeguards for a JAMA clinical manuscript (RCT, cohort, diagnostic, or systematic review). Strengthens design choices; it does NOT pick the reporting checklist or run the statistics.
---
# Study Design & Internal Validity (jama-study-design)
## When to trigger
- Choosing or defending the design: RCT vs cohort vs case-control vs diagnostic
- A reviewer will ask whether the analysis is intention-to-treat or per-protocol
- Bias, confounding, or missing data threaten the primary inference
- The design and the reporting checklist need to be aligned before writing
## Design-specific safeguards JAMA reviewers expect
### Randomized clinical trials
- A single, **pre-specified primary outcome**; secondary outcomes clearly labeled
- Adequate randomization (sequence generation) and **allocation concealment**
- Blinding of participants, clinicians, outcome assessors where feasible — state what was blinded
- **Intention-to-treat** as the primary analysis; per-protocol only as secondary/sensitivity
- A priori **sample-size / power** calculation tied to the primary outcome
- Pre-defined stopping rules and handling of interim analyses
### Cohort / case-control (observational)
- Explicit **confounding** control: prespecified covariates, adjustment strategy, DAG reasoning
- Clear definitions of exposure, outcome, and follow-up windows; avoid immortal-time bias
- Selection-bias and information-bias appraisal; how participants entered the sample
- **Association, not causation** — design and language must respect this
### Diagnostic-accuracy studies
- Pre-specified reference standard, applied to all participants, blinded to index test
- Consecutive or random enrollment; report spectrum of disease
- Pre-defined thresholds; report sensitivity/specificity/predictive values with CIs
### Systematic reviews / meta-analyses
- Pre-registered protocol (e.g., PROSPERO), pre-specified eligibility and outcomes
- Comprehensive, reproducible search; duplicate screening and extraction
- Risk-of-bias assessment; pre-planned heterogeneity and sensitivity analyses
## Decision table
| Question | Design / action |
|-----------------------------------------------------------|-----------------------------------------|
| Does an intervention cause an outcome? | RCT; if infeasible, strong quasi-design |
| What is the prognosis / risk of an exposure? | Prospective cohort with confounder plan |
| How accurate is a test? | Diagnostic-accuracy study (vs reference)|
| What does the totality of evidence show? | Systematic review ± meta-analysis |
| Rare outcome, exposure already occurred | Case-control (watch selection bias) |
## Checklist
- [ ] Primary outcome is single, pre-specified, patient-relevant
- [ ] For RCTs: randomization, allocation concealment, blinding stated; ITT is primary
- [ ] Sample-size / power calculation present and tied to the primary outcome
- [ ] Confounding/bias strategy explicit and pre-specified (observational)
- [ ] Reference standard and blinding defined (diagnostic)
- [ ] Protocol pre-registered (RCT and systematic review)
- [ ] Missing-data handling pre-specified (not improvised post hoc)
- [ ] Design choice matches the EQUATOR checklist you will use
## Anti-patterns
- Promoting a secondary or post hoc outcome to "primary" after seeing results
- Per-protocol analysis presented as primary for an RCT
- "Adjusted for everything" with no pre-specified covariate rationale
- Causal claims from an observational design
- Reference standard chosen or applied after knowing the index-test result
- No power calculation, then attributing a null result to "trends"
## Output format
```
【Design】RCT / cohort / case-control / diagnostic / systematic review
【Primary outcome】... (pre-specified: yes/no)
【Key validity safeguards in place】...
【Validity gaps to fix】...
【Causal vs associational claim】...
【Matching EQUATOR checklist】CONSORT / STROBE / STARD / PRISMA
【Next skill】jama-reporting-standards
```
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!